The ROE as of July 2025 (TTM) for AC Immune S.A. (ACIU) is -45.22%

According to AC Immune S.A.’s latest financial reports and current stock price. The company's current ROE is -45.22%. This represents a change of 274.10% compared to the average of -12.09% of the last 4 quarters.

AC Immune S.A. (ACIU) Historical ROE (quarterly & annually)

How has ACIU ROE performed in the past?

The mean historical ROE of AC Immune S.A. over the last ten years is -19.23%. The current -45.22% ROE has changed 135.14% with respect to the historical average. Over the past ten years (40 quarters), ACIU's ROE was at its highest in in the September 2015 quarter at 41.74%. The ROE was at its lowest in in the March 2025 quarter at -20.07%.

AC Immune S.A. (ACIU) ROE by Quarter and Year

Discovering the peaks and valleys of AC Immune S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AC Immune S.A. (ACIU) Average ROE

How has ACIU ROE performed in the past?

The current ROE of AC Immune S.A. (ACIU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AC Immune S.A. (ACIU) ROE vs. Peers

How is ACIU’s ROE compared to its peers?

AC Immune S.A.’s ROE is greater than PMV Pharmaceuticals, Inc. (-32.54%), greater than Eliem Therapeutics, Inc. (-43.95%), greater than MediciNova, Inc. (-20.77%), greater than Pharvaris N.V. (-54.35%), greater than PepGen Inc. (-81.26%), greater than REGENXBIO Inc. (-53.29%), greater than Anebulo Pharmaceuticals, Inc. (-90.11%), greater than Invivyd, Inc. (-165.23%), greater than Abeona Therapeutics Inc. (-86.45%), less than Black Diamond Therapeutics, Inc. (4.70%), less than Synlogic, Inc. (10.91%), less than eFFECTOR Therapeutics, Inc. (723.15%), less than Galera Therapeutics, Inc. (11.31%), greater than Icosavax, Inc. (-35.64%), greater than Homology Medicines, Inc. (-447.33%), less than Stoke Therapeutics, Inc. (19.08%), greater than Atreca, Inc. (-77.59%), greater than 4D Molecular Therapeutics, Inc. (-33.27%), less than Aerovate Therapeutics, Inc. (200.78%), greater than Acrivon Therapeutics, Inc. Common Stock (-44.66%), less than Opthea Limited (543.34%), greater than AN2 Therapeutics, Inc. (-53.17%),

Build a custom stock screener for AC Immune S.A. (ACIU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AC Immune S.A. (ACIU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.